The impact of Ras/MAPK/S6K signaling pathway on prediction of clinical outcome in metastatic Her-2 positive breast cancer patients treated with trastuzumab.

Authors

SVOBODA Marek GRELL Peter NAVRÁTIL Jiří

Year of publication 2014
Type Article in Periodical
Magazine / Source Cancer Research 2014;74(19 Suppl):Abstract nr LB-181.
Citation

You are running an old browser version. We recommend updating your browser to its latest version.

More info